Plasma aldosterone, vasopressin and atrial natriuretic peptide in hypovolaemia: A preliminary comparative study of neonatal and mature horses

Equine Veterinary Journal

Volumn 40, Issue 1, 2008, Pages 64-69

  Hollis, A R ^a   Boston, R C ^a   Corley, K T T ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Anglesey Lodge Equine Hospital   (Ireland)

Author keywords

Aldosterone; Atrial natriuretic peptide; Horse; Hypovolaemia; Vasopressin

Indexed keywords

EQUIDAE;

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; VASOPRESSIN DERIVATIVE;

AGING; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BODY FLUID; COMPARATIVE STUDY; FEMALE; FLUID THERAPY; HORSE; HORSE DISEASE; HYPOVOLEMIA; MALE; METABOLISM; NEWBORN; NONPARAMETRIC TEST; TREATMENT OUTCOME;

AGING; ALDOSTERONE; ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; BODY FLUIDS; FEMALE; FLUID THERAPY; HORSE DISEASES; HORSES; HYPOVOLEMIA; MALE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VASOPRESSINS;

EID: 40949146239     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516407X235795     Document Type: Article

References (43)

1. Airasmaa, H., Erb, H., Lamb, S., Vincent, S., Ludders, J. and Gleed, R. (2005) Plasma arginine vasopressin (AVP) concentrations in horses undergoing colic surgery. In: Proceedings of the 8th International Colic Research Symposium, Quebec City, Canada. pp 35-37.
2. Aiura, K., Ueda, M., Endo, M. and Kitajima, M. (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit. Care Med. 23, 1898-1906.
3. Argenziano, M., Choudhri, A.F., Oz, M.C., Rose, E.A., Smith, C.R. and Landry, D.W. (1997) A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory chock after left ventricular assist device placement. Circulation 96, 286-290.
4. Argenziano, M., Chen, J.M., Choudhri, A.F., Cullinane, S., Garfein, E., Weinberg, A.D., Smith, C.R., Rose, E.A., Landry, D.W. and Oz, M.C. (1998) Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J. Thorac. Cardiovasc. Surg. 116, 973-980.
5. Bayard, F., Alicandri, C., Beitins, I., Lubash, G., Kowarski, A. and Migeon, C. (1971) A dynamic study of plasma renin activity and aldosterone concentration in normal and hypertensive subjects. Metabolism 20, 513-519.
6. Beitins, I., Bayard, F., Levitsky, L., Ances, I., Kowarski, A. and Migeon, C. (1972) Plasma aldosterone concentration at delivery and during the newborn period. J. clin. Invest. 51, 386-394.
7. Buchanan, B., Sommardahl, C., Rohrbach, B. and Andrews, F. (2005) Effect of a 24-hour infusion of an isotonic electrolyte replacement fluid on the renal clearance of electrolytes in healthy neonatal foals. J. Am. vet. med. Ass. 227, 1123-1129.
8. Clark, E., Gantley, B. and Moore, J. (1991) Effects of slow infusion of a low dosage of endotoxin on systemic haemodynamics in conscious horses. Equine vet. J. 23, 18-21.
9. Corley, K. (2002) Monitoring and treating haemodynamic disturbances in critically ill neonatal foals. Part 1: Haemodynamic monitoring. Equine vet. Educ. 14, 270-279.
10. Corley, K. (2004a) Inotropes and vasopressors in adults and foals. Vet. clin. Equine 20, 77-106.
11. Corley, K. (2004b) Fluid therapy. In: Equine Clinical Pharmacology, W.B. Saunders, Philadelphia. pp 327-364.
12. Corley, K. and Axon, J. (2005) Resuscitation and emergency management for neonatal foals. Vet. clin. Equine 21, 431-455.
13. Dillon, M., Gillin, M., Ryness, J. and deSwiet, M. (1976) Plasma renin activity and aldosterone concentration in the human newborn. Archs. Dis. Childh. 51, 537-540.
14. Dillon, M., Rajani, K., Shah, V., Ryness, J. and Milner, R. (1978) Renin and aldosterone response in human newborns to acute change in blood volume. Archs. Dis. Childh. 53, 461-467.
15. Donckier, J., Michel, L., Collard, E., Berbinschi, A., Ketelslegers, J., Harvengt, C. and Buysschaert, M. (1988) Parallel changes of atrial natriuretic factor and catecholamines for pheochromocytoma. Am. J. Med. 85, 278-279.
16. Ganong, W. (1999) Cardiovascular homeostasis in health and disease. In: Review of Medical Physiology, Appleton and Lange, Stamford. pp 601-616.
17. Giussani, D., Forhead, A. and Fowden, A. (2005) Development of cardiovascular function in the horse fetus. J. Physiol. 565, 1019-1030.
18. Godard, C., Gaillard, R. and Vallotton, M. (1976) The renin-angiotensin-aldosterone system in mother and fetus at term. Nephron 17, 353-360.
19. Golda, J., Diversa, T., Bartomb, M., Lamba, S., Placea, N., Mohammeda, H. and Bainc, F. (2006) ACTH, cortisol and vasopressin levels of septic (survivors and nonsurvivors) in comparison to normal foals. J. vet. intern. Med. 20, 720.
20. Hinder, F., Booke, M., Traber, L. and Traber, D. (1996) Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit. Care Med. 24, 131-136.
21. Honour, J., Shackleton, C. and Valman, H. (1974) Sodium homeostasis in preterm infants. Lancet ii, 1147.
22. Jochberger, S., Mayr, V., Luckner, G., Wenzel, V., Ulmer, H., Schmid, S., Knotzer, H., Pajk, W., Hasibeder, W., Friesenecker, B., Mayr, A. and Dunser, M. (2006) Serum vasopressin concentrations in critically ill patients. Crit. Care Med. 34, 293-299.
23. Landry, D. and Oliver, J. (2001) The pathogenesis of vasodilatory shock. N. Engl. J. Med. 345, 588-595.
24. Landry, D., Levin, H., Gallant, E., Ashton, R., Seo, S., D'Alessandro, D., Oz, M. and Oliver, J. (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95, 1122-1125.
25. Lavoie, J., Madigan, J., Cullor, J. and Powell, W. (1990) Haemodynamic, pathological, haematological and behavioural changes during endotoxin infusion in equine neonates. Equine vet. J. 22, 23-29.
26. Levin, E., Gardner, D. and Samson, W. (1998) Natriuretic peptides. N. Engl. J. Med. 339, 321-328.
27. Lubbesmeyer, H., Woodson, L., Traber, L., Flynn, J., Herndon, D. and Traber, D. (1988) Immunoreactive atrial natriuretic factor is increased in ovine model of endotozemia. Am. J. Physiol. 254, R567-571.
28. Mitaka, C., Nagura, T., Sakanishi, N., Tsunoda, Y. and Toyooka, H. (1990) Plasma alpha-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: preliminary study. Crit. Care Med. 18, 1201-1203.
29. Muir, W. (1992) Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses. Equine vet. J., Suppl. 11, 24-29.
30. O'Connor, S., Gardner, D., Ousey, J., Holdstock, N., Rossdale, P., Edwards, C., Fowden, A. and Giussani, D. (2005) Development of baroreflex and endocrine responses to hypotensive stress in newborn foals and lambs. Eur. J. Physiol. 450, 298-306.
31. Palmer, J. (2004) Fluid therapy in the neonate: not your mother's fluid space. Vet. Clin. N. Am.: Equine Pract. 20, 63-75.
32. Putensen, C., Mutz, N., Pomaroli, A., Lingnau, W., Artner-Dworzak, E. and Puschendorf, B. (1992) Atrial natriuretic factor relase during hypovolemia and after volume replacement. Crit. Care Med. 20, 984-989.
33. Raff, H., Findling, J., Diaz, S., Majmudar, M. and Waters, V. (1990) Aldosterone control in critically ill patients: ACTH, metoclopraminde, and atrial natriuretic peptide. Crit. Care Med. 18, 915-920.
34. Raux-Eurin, M., Pham-Huu-Trung, M., Marrec, D. and Girard, F. (1977) Plasma aldosterone concentrations during the neonatal period. Pediat. Res. 11, 182-185.
35. Redl, G., Woodson, L., Traber, L.D., Rogers, C.S., Abdi, S., Flynn, J.T., Herndon, D.N. and Traber, D.L. (1992) Mechanism of immunoreactive atrial natriuretic factor release in an ovine model of endotoxemia. Circ. Shock 38, 34-41.
36. Rose, R. (1981) A physiological approach to fluid and electrolyte therapy in the horse. Equine vet. J. 13, 7-14.
37. Shackford, S., Norton, C., Ziegler, M. and Wilner, K. (1988) The effect of hemorrhage and resuscitation on serum levels of immunoreactive atrial natriuretic factor. Ann. Surg. 207, 195-200.
38. Sharshar, T., Blachard, A., Paillard, M., Raphael, J., Gajdos, P. and Annane, D. (2003) Circulating vasopressin levels in septic shock. Crit. Care Med. 31, 1752-1758.
39. Skarda, R. and Muir, W. (1996) Analgesic, hemodynamic, and respiratory effects of caudally administered xylazine hydrochloride solution in mares. Am. J. vet. Res. 57, 193-200.
40. Sulyok, E., Nemeth, M., Tenyi, I., Csaba, I., Varga, F., Gyory, E. and Thyrzo, V. (1979) Relationship between maturity, electrolyte balance and the function of the renin-angiotensin-aldosterone system in newborn infants. Biol. Neonate 35, 60-65.
41. Thomas, W., Madigan, J., Backus, K. and Powell, W. (1987) Systemic and pulmonary haemodynamics in normal neonatal foals. J. Reprod. Fert., Suppl. 35, 623-628.
42. Tsuneyoshi, I., Yamada, H., Kakihana, Y., Nakamura, M., Nakano, Y. and Boyle, W. (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit. Care Med. 29, 487-493.
43. Witthaut, R. (2004) Science review: Natriuretic peptides in critical illness. Critical Care 8, 342-349.